Project Number 1R01AG058468-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for ADUCANUMAB ALZHEIMER'S PREVENTION TRIAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator REIMAN, ERIC MICHAEL Principal Investigator First Name ERIC MICHAEL Principal Investigator Last Name REIMAN Awardee Organization BANNER ALZHEIMER'S INSTITUTE Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-160: NIH Research Project Grant (Parent R01) FY Overall Cost $5,670,134 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
